Wednesday, September 16, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $331.34 -0.52%
MSFT $497.12 -1.64%
GOOGL $344.98 -1.26%
AMZN $248.42 -2.02%
TSLA $356.58 -0.67%
META $670.24 +0.70%
NVDA $212.17 +0.57%
JPM $352.49 +0.67%
BTC $33.64 -3.64%
ETH $23.05 -4.87%
AAPL
$331.34
▼ 0.52%
MSFT
$497.12
▼ 1.64%
GOOGL
$344.98
▼ 1.26%
AMZN
$248.42
▼ 2.02%
TSLA
$356.58
▼ 0.67%
META
$670.24
▲ 0.70%
NVDA
$212.17
▲ 0.57%
JPM
$352.49
▲ 0.67%
TechCrunch
When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs's words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.
technology  Jul 12, 2026
TechCrunch
Last weekend’s brutal NYC heat wave had me craving a frozen drink almost every afternoon. Normally, that would mean sweating through a walk to 7-Eleven for a slurpee. This time, though, I stayed home and put the new Ninja Slushi Twist to the test. Ninja’s latest slushie machine builds on the popularity of the original […]
technology  Jul 11, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free